tetraethylammonium has been researched along with medetomidine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dezaki, K; Kakei, M; Kawakami, M; Kodera, SY; Murayama, T; Yada, T; Yoshida, M | 1 |
1 other study(ies) available for tetraethylammonium and medetomidine
| Article | Year |
|---|---|
Inhibition of insulin secretion from rat pancreatic islets by dexmedetomidine and medetomidine, two sedatives frequently used in clinical settings.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Dexmedetomidine; GTP-Binding Proteins; Hypnotics and Sedatives; Insulin; Insulin Antagonists; Insulin Secretion; Islets of Langerhans; Male; Medetomidine; omega-Conotoxins; Pertussis Toxin; Potassium Channels, Voltage-Gated; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Tetraethylammonium; Yohimbine | 2013 |